| Link Pharma Chem Ltd | Industry : (Chemicals) | |
|---|---|---|
|
BSE Code : 524748 |
NSE Symbol : - |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE302F01011 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 29.44 |
Market Cap(₹Cr) : 14.27 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 6.29 | 7.81 | 6.45 | 5.34 | 4.80 | 8.85 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 6.29 | 7.81 | 6.45 | 5.34 | 4.80 | 8.85 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.05 | 0.21 | 0.12 | -0.56 | 0.36 | 0.27 |
| Total Income | 6.34 | 8.02 | 6.56 | 4.78 | 5.16 | 9.12 |
| Total Expenditure | 5.95 | 7.17 | 6.67 | 5.23 | 5.10 | 8.30 |
| PBIDT | 0.39 | 0.85 | -0.11 | -0.45 | 0.06 | 0.82 |
| Interest | 0.13 | 0.10 | 0.14 | 0.21 | 0.21 | 0.22 |
| PBDT | 0.26 | 0.75 | -0.25 | -0.66 | -0.15 | 0.60 |
| Depreciation | 0.25 | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 |
| Tax | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.11 | -0.16 | -0.22 | -0.08 | 0.06 |
| Reported Profit After Tax | 0.02 | 0.40 | -0.35 | -0.67 | -0.31 | 0.30 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.02 | 0.40 | -0.35 | -0.67 | -0.31 | 0.30 |
| EPS (Unit Curr.) | 0.03 | 0.91 | -0.79 | -1.50 | -0.69 | 0.67 |
| EPS (Adj) (Unit Curr.) | 0.03 | 0.91 | -0.79 | -1.50 | -0.69 | 0.67 |
| Calculated EPS (Unit Curr.) | 0.04 | 0.91 | -0.79 | -1.50 | -0.69 | 0.67 |
| Calculated EPS (Adj) (Unit Curr.) | 0.04 | 0.91 | -0.79 | -1.50 | -0.69 | 0.67 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.14 | 3.62 | -3.15 | -6.01 | -2.76 | 2.67 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.14 | 3.62 | -3.15 | -6.01 | -2.76 | 2.67 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 4.44 | 4.44 | 4.44 | 4.44 | 4.44 | 4.44 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 6.20 | 10.88 | -1.71 | -8.43 | 1.25 | 9.27 |
| PBDTM(%) | 4.13 | 9.60 | -3.88 | -12.36 | -3.13 | 6.78 |
| PATM(%) | 0.32 | 5.12 | -5.43 | -12.55 | -6.46 | 3.39 |